Metraipolis › archive › dc_bcc14455541b

In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effects — Europe PMC PMID:42092963

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42092963
DOI
10.1186/s12935-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-02T15:37:43.316Z
SHA-256 of the archived text
f2ce674b8976a7a278e63c16a58dd2062f3a56a62b4a354c299eca9d0cf88af4
Stable URL of this page
https://metraipolis.com/documento/dc_bcc14455541b

How to cite

In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effects — Europe PMC PMID:42092963 — Europe PMC (en), https://europepmc.org/article/MED/42092963 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcc14455541b (Metraipolis archive dc_bcc14455541b, sha256 f2ce674b8976a7a278e63c16a58dd2062f3a56a62b4a354c299eca9d0cf88af4)
BibTeX
@misc{dcbcc14455541b,
  title = {In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effects — Europe PMC PMID:42092963},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42092963},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcc14455541b; sha256 f2ce674b8976a7a278e63c16a58dd2062f3a56a62b4a354c299eca9d0cf88af4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42092963. Agents can read the archived copy with the MCP tool read_document.